Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Advanced Prostate Cancer × Docetaxel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 119 Carcinoma, Non-Small-Cell Lung 86 Prostatic Neoplasms 43 Lung Neoplasms 26 Neoplasm Metastasis 18 Stomach Neoplasms 16 Nasopharyngeal Carcinoma 16 Parkinson Disease 4, Autosomal Dominant Lewy Body 14 Neoplasms 14 Squamous Cell Carcinoma of Head and Neck 12 Esophageal Neoplasms 10 Head and Neck Neoplasms 7 Esophageal Squamous Cell Carcinoma 7 Urinary Bladder Neoplasms 6 Ovarian Neoplasms 6 Carcinoma 6 Adenocarcinoma 6 Fallopian Tube Neoplasms 5 Carcinoma, Squamous Cell 5 Recurrence 4 Inflammatory Breast Neoplasms 4 HER2-positive Breast Cancer 4 Endometrial Neoplasms 4 Adenocarcinoma Of Esophagus 4 Triple Negative Breast Neoplasms 3 Primary Breast Cancer 3 Carcinoma, Transitional Cell 3 Carcinoma, Ovarian Epithelial 3 Uterine Cervical Neoplasms 2 Sarcoma 2

Interventions

Leuprolide 1 Goserelin 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01224405 2010-10-20

PON-PC-02

University of Turin, Italy

Phase 3 Unknown

Advanced Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡